186 related articles for article (PubMed ID: 14959696)
21. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of nandrolone decanoate in wasting associated with HIV.
Saha B; Rajadhyaksha GC; Ray SK
J Indian Med Assoc; 2009 May; 107(5):295-9. PubMed ID: 19886384
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
[TBL] [Abstract][Full Text] [Related]
25. Use of bioelectrical impedance analysis to determine body composition changes in HIV-associated wasting.
Klauke S; Fischer H; Rieger A; Frühauf L; Staszewski S; Althoff PH; Helm EB
Int J STD AIDS; 2005 Apr; 16(4):307-13. PubMed ID: 15899085
[TBL] [Abstract][Full Text] [Related]
26. Weight loss and wasting in patients infected with human immunodeficiency virus.
Grinspoon S; Mulligan K;
Clin Infect Dis; 2003 Apr; 36(Suppl 2):S69-78. PubMed ID: 12652374
[TBL] [Abstract][Full Text] [Related]
27. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy.
Paton NI; Sangeetha S; Earnest A; Bellamy R
HIV Med; 2006 Jul; 7(5):323-30. PubMed ID: 16945078
[TBL] [Abstract][Full Text] [Related]
28. HIV/AIDS wasting syndrome in Manipur - a case report.
Singh TN; Singh HL
Kathmandu Univ Med J (KUMJ); 2005; 3(4):425-7. PubMed ID: 16449850
[TBL] [Abstract][Full Text] [Related]
29. Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
Justice AC; Stein DS; Fusco GP; Sherrill BH; Fusco JS; Danehower SC; Becker SL; Hansen NI; Graham NM;
J Clin Epidemiol; 2004 Jan; 57(1):89-97. PubMed ID: 15019015
[TBL] [Abstract][Full Text] [Related]
30. ESPEN Guidelines on Enteral Nutrition: Wasting in HIV and other chronic infectious diseases.
Ockenga J; Grimble R; Jonkers-Schuitema C; Macallan D; Melchior JC; Sauerwein HP; Schwenk A; ; Süttmann U;
Clin Nutr; 2006 Apr; 25(2):319-29. PubMed ID: 16698147
[TBL] [Abstract][Full Text] [Related]
31. Role of nutrition in the management of HIV infection/AIDS.
Sherlekar S; Udipi SA
J Indian Med Assoc; 2002 Jun; 100(6):385-90. PubMed ID: 12416672
[TBL] [Abstract][Full Text] [Related]
32. Comparing megestrol acetate therapy with oxandrolone therapy for HIV-related weight loss: similar results in 2 months.
Mwamburi DM; Gerrior J; Wilson IB; Chang H; Scully E; Saboori S; Miller L; Forfia J; Albrecht M; Wanke CA
Clin Infect Dis; 2004 Mar; 38(6):895-902. PubMed ID: 14999637
[TBL] [Abstract][Full Text] [Related]
33. Increased body weight and improved quality of life in AIDS patients following V-1 Immunitor administration.
Jirathitikal V; Metadilogkul O; Bourinbaiar AS
Eur J Clin Nutr; 2004 Jan; 58(1):110-5. PubMed ID: 14679375
[TBL] [Abstract][Full Text] [Related]
34. Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy.
Mwamburi DM; Wilson IB; Jacobson DL; Spiegelman D; Gorbach SL; Knox TA; Wanke CA
Clin Infect Dis; 2005 Jan; 40(1):167-73. PubMed ID: 15614708
[TBL] [Abstract][Full Text] [Related]
35. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
Young J; Rickenbach M; Weber R; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC
Antivir Ther; 2005; 10(1):73-81. PubMed ID: 15751765
[TBL] [Abstract][Full Text] [Related]
36. How to recognize wasting syndrome.
Baker B
Posit Aware; 1998; 9(2):21. PubMed ID: 11365221
[TBL] [Abstract][Full Text] [Related]
37. [HIV wasting syndrome].
Osoegawa M; Kira J
Ryoikibetsu Shokogun Shirizu; 2001; (35):185-8. PubMed ID: 11555906
[No Abstract] [Full Text] [Related]
38. L-ornithine alpha-ketoglutarate in HIV infection: effects on muscle, gastrointestinal, and immune functions.
Karsegard VL; Raguso CA; Genton L; Hirschel B; Pichard C
Nutrition; 2004 Jun; 20(6):515-20. PubMed ID: 15165613
[TBL] [Abstract][Full Text] [Related]
39. Testosterone replacement for hypogonadism: clinical findings and best practices.
Hengge UR
AIDS Read; 2003 Dec; 13(12 Suppl):S15-21. PubMed ID: 14959695
[TBL] [Abstract][Full Text] [Related]
40. Weight loss and disease progression in HIV infection.
Wheeler DA
AIDS Read; 1999 Aug; 9(5):347-53. PubMed ID: 12737124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
